Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

El VHIR va participar activament en l'assaig clínic d'aquesta vacuna que avaluava la seguretat, la tolerabilitat i l'eficàcia.

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

The trial, which already has AEMPS authorisation, will be conducted in Spain, Portugal and Italy.

In addition to COVID-19, new vaccines have been presented to combat flu, the herpes-zoster virus, meningococcus and pneumococcus.

The jury unanimously recognised her efforts in the fight against COVID-19 and the cooperation with the care sector for dependent elderly people.

Vall d’Hebron is looking for volunteers over the age of 18 who have received the Pfizer-BioNTech Comirnaty vaccine against COVID-19 at least 6 months ago.